Global Cell Harvesting Market - Forecasts From 2018 to 2023
The global cell harvesting market is expected to reach US$547.050 million by 2023 from US$315.533 million in 2017 growing at a CAGR of 9.61%. Cell harvesting refers to the technique of collecting the stem cells for the various therapeutic purpose. Stem cells are the primitive undifferentiated cells that have the ability to differentiate into various cell types of the body such as liver cells, muscle cells, blood cells, and other cells with specific functions. Stem cell harvesting helps in treating several diseases, such as cancers, blood disorders, immune deficiency diseases with researches underway to determine whether stem cell therapy may be useful in treating other conditions, including diabetes, heart disease, Parkinson's disease, and spinal cord injury. The market is expected to show a significant growth during the forecast period owing to the rising investments in regenerative medicine and cell-based research. Growth in the biotechnology industry will also have a positive impact on the cell harvesting market. However, ethical issues pertaining to the stem cell therapies and high cost of the therapy might restrict the growth of the market during the give time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Cell Harvesting market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Cell Harvesting market.
Major industry players profiled as part of the report are Aspire Medical Innovation, CTIBiotech Corporation and Tomtec among others.
Segmentation
By Cell Harvesting Type
Manual Cell Harvesting
Automated Cell Harvesting
By Stem Cell Type
Umbilical Cord Stem Cells
Adult Stem Cells
Fetal Stem Cells
Embryonic Stem Cells
Others
By Application
Cancer
Blood Disorders
Genetic Disorders
Others
By End Users
Biotechnology & Biopharmaceutical Companies
Hospitals
Research Centers
By Geography
North America
United States
Canada
South America
Europe
United Kingdom
Germany
France
Others
Middle East and Saudi Arabia
Asia Pacific
China
Japan
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Cell Harvesting market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Cell Harvesting market.
Major industry players profiled as part of the report are Aspire Medical Innovation, CTIBiotech Corporation and Tomtec among others.
Segmentation
By Cell Harvesting Type
Manual Cell Harvesting
Automated Cell Harvesting
By Stem Cell Type
Umbilical Cord Stem Cells
Adult Stem Cells
Fetal Stem Cells
Embryonic Stem Cells
Others
By Application
Cancer
Blood Disorders
Genetic Disorders
Others
By End Users
Biotechnology & Biopharmaceutical Companies
Hospitals
Research Centers
By Geography
North America
United States
Canada
South America
Europe
United Kingdom
Germany
France
Others
Middle East and Saudi Arabia
Asia Pacific
China
Japan
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL CELL HARVESTING MARKET FORECAST BY CELL HARVESTING TYPE
5.1. Manual Cell Harvesting
5.2. Automated Cell Harvesting
6. GLOBAL CELL HARVESTING MARKET FORECAST BY STEM CELL TYPE
6.1. Umbilical Cord Stem Cells
6.2. Adult Stem Cells
6.3. Fetal Stem Cells
6.4. Embryonic Stem Cells
6.5. Others
7. GLOBAL CELL HARVESTING MARKET FORECAST BY APPLICATION
7.1. Cancer
7.2. Blood Disorders
7.3. Genetic Disorders
7.4. Others
8. GLOBAL CELL HARVESTING TEST MARKET FORECAST BY END USERS
8.1. Biotechnology & Biopharmaceutical Companies
8.2. Hospitals
8.3. Research Centers
9. GLOBAL CELL HARVESTING TEST MARKET FORECAST BY GEOGRAPHY
9.1. North America
9.1.1. The U.S
9.1.2. Canada
9.2. South America
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. Others
10. COMPETITIVE INTELLIGENCE
10.1. Market Share Analysis
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILES
11.1. PerkinElmer Inc.
11.1.1. Overview
11.1.2. Financials
11.1.3. Product and Services
11.1.4. Recent Developments
11.2. Tomtec
11.2.1. Overview
11.2.2. Financials
11.2.3. Product and Services
11.2.4. Recent Developments
11.3. CTIBiotech
11.3.1. Overview
11.3.2. Financials
11.3.3. Product and Services
11.3.4. Recent Developments
11.4. RegenMed Systems Inc.
11.4.1. Overview
11.4.2. Financials
11.4.3. Product and Services
11.4.4. Recent Developments
11.5. Aspire Medical Innovation
11.5.1. Overview
11.5.2. Financials
11.5.3. Product and Services
11.5.4. Recent Developments
11.6. Brandel
11.6.1. Overview
11.6.2. Financials
11.6.3. Product and Services
11.6.4. Recent Developments
11.7. Inotech Biosystems International, Inc.
11.7.1. Overview
11.7.2. Financials
11.7.3. Product and Services
11.7.4. Recent Developments
11.8. GE Healthcare Life Sciences
11.8.1. Overview
11.8.2. Financials
11.8.3. Product and Services
11.8.4. Recent Developments
11.9. Sartorius
11.9.1. Overview
11.9.2. Financials
11.9.3. Product and Services
11.9.4. Recent Developments
11.10. Terumo Corporation
11.10.1. Overview
11.10.2. Financials
11.10.3. Product and Services
11.10.4. Recent Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL CELL HARVESTING MARKET FORECAST BY CELL HARVESTING TYPE
5.1. Manual Cell Harvesting
5.2. Automated Cell Harvesting
6. GLOBAL CELL HARVESTING MARKET FORECAST BY STEM CELL TYPE
6.1. Umbilical Cord Stem Cells
6.2. Adult Stem Cells
6.3. Fetal Stem Cells
6.4. Embryonic Stem Cells
6.5. Others
7. GLOBAL CELL HARVESTING MARKET FORECAST BY APPLICATION
7.1. Cancer
7.2. Blood Disorders
7.3. Genetic Disorders
7.4. Others
8. GLOBAL CELL HARVESTING TEST MARKET FORECAST BY END USERS
8.1. Biotechnology & Biopharmaceutical Companies
8.2. Hospitals
8.3. Research Centers
9. GLOBAL CELL HARVESTING TEST MARKET FORECAST BY GEOGRAPHY
9.1. North America
9.1.1. The U.S
9.1.2. Canada
9.2. South America
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. Others
10. COMPETITIVE INTELLIGENCE
10.1. Market Share Analysis
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILES
11.1. PerkinElmer Inc.
11.1.1. Overview
11.1.2. Financials
11.1.3. Product and Services
11.1.4. Recent Developments
11.2. Tomtec
11.2.1. Overview
11.2.2. Financials
11.2.3. Product and Services
11.2.4. Recent Developments
11.3. CTIBiotech
11.3.1. Overview
11.3.2. Financials
11.3.3. Product and Services
11.3.4. Recent Developments
11.4. RegenMed Systems Inc.
11.4.1. Overview
11.4.2. Financials
11.4.3. Product and Services
11.4.4. Recent Developments
11.5. Aspire Medical Innovation
11.5.1. Overview
11.5.2. Financials
11.5.3. Product and Services
11.5.4. Recent Developments
11.6. Brandel
11.6.1. Overview
11.6.2. Financials
11.6.3. Product and Services
11.6.4. Recent Developments
11.7. Inotech Biosystems International, Inc.
11.7.1. Overview
11.7.2. Financials
11.7.3. Product and Services
11.7.4. Recent Developments
11.8. GE Healthcare Life Sciences
11.8.1. Overview
11.8.2. Financials
11.8.3. Product and Services
11.8.4. Recent Developments
11.9. Sartorius
11.9.1. Overview
11.9.2. Financials
11.9.3. Product and Services
11.9.4. Recent Developments
11.10. Terumo Corporation
11.10.1. Overview
11.10.2. Financials
11.10.3. Product and Services
11.10.4. Recent Developments
